Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Sherblom currently holds 452,244 shares of Comera Life Sciences Holdings, Inc. (CMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Sherblom has been a net buyer of CMRA stock. They have purchased $201.2K and sold $0 worth of shares.
James Sherblom's most recent insider trade was on Jan 4, 2023, when they sold 81,081 shares at $1.23 per share.
James Sherblom serves as Executive at Comera Life Sciences Holdings, Inc. (CMRA). They have executed 3 insider transactions totaling $201.2K over their tenure at the company.
James Sherblom holds the position of Executive at Comera Life Sciences Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
James Sherblom has shown a buying trading pattern, with $201.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Sherblom was on Sep 12, 2022, when they purchased $101.5K worth of CMRA shares. This transaction involved 50,000 shares at $2.03 per share.
James Sherblom currently owns 452,244 shares of Comera Life Sciences Holdings, Inc. (CMRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Sherblom's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Sherblom has 3 Form 4 filings on record as an insider at Comera Life Sciences Holdings, Inc..
Set alerts for James Sherblom and 40,000+ other insiders.